Algo version: 0.98b
Laboratorio Reig Jofre, is listed at the EURONEXT Exchange
Laboratorio Reig Jofre, [RJF.MC]
EURONEXT Sector: Healthcare Industry:Drug Manufacturers—Specialty & Generic

Is Laboratorio Reig Jofre, stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

Yes, Laboratorio Reig Jofre, pays dividends. Last time was Tuesday 4th of June 2024 where the investors holding the stock on Friday 17th of May 2024 were paid €0.04 per share. Over the last 9 times between 2013 and 2024, Laboratorio Reig Jofre, has paid €1.2876 with an average of €0.14 per share.

Sorry, we do not have any analyst data for this ticker

We cannot find data for Laboratorio Reig Jofre, 10 years ago, but if you had invested on Monday 9th of September 2019 when the price was €2.38, you would have made a profit of €0.340 per share or 14.29%

No, the average daily trading liquidity for Laboratorio Reig Jofre, is €16 668 thousand. Trading in stocks with this little trading liquidity is very dangerous, and you can get into a situation where it will be hard to trade your stocks. In addition, these types of stocks usually have very high volatility.

Laboratorio Reig Jofre, has a normal ratio of the business financed by loans. This puts the company at some risk in periods of high inflation where borrowing costs usually go up. With a normal cash flow to debt ratio of 0.23, the company's ability to pay off the debt is normal. The company has a very low net profit margin of 2.73%, which is challenging.

We have calculated the inflation risk for Laboratorio Reig Jofre, to be low [0.5 of 1]

US inflation for July 2024 was 0.15%. Over the last 12 months, the US inflation is 2.92%. The 10-year treasury yield that indicates the future interest level is currently 3.72 and is down -0.95 over the last 30 days.